Platelets play a critical role in the pathophys iology of amaurosis fugax. Emboli to retinal vessels ap parently produce amaurosis but, in addition, we propose that augmented vasoconstrictor responses and vaso spasm may contribute to amaurosis. In this study we tested the hypothesis that constrictor responses of retinal vessels to serotonin, which is released when platelets ag gregate, are potentiated in experimental atherosclerosis. Blood flow to the retina was measured in normal and atherosclerotic cynomolgus monkeys. In normal mon keys, infusion of serotonin did not alter flow to the retina. In atherosclerotic monkeys, infusion of serotonin re-
Amaurosis fugax is fleeting blindness that is pro duced by transient retinal ischemia, which often forewarns of impending stroke (Fawcett et aI., 1985; Hurwitz et aI., 1985; Munga and Baker, 1977) . In the past, vasospasm was thought to produce transient ischemic attacks (TIAs) and amaurosis, but this hypothesis lost favor when strong evidence was obtained that platelets play a critical role in the pathophysiology of TIAs (Adams et aI., 1983; Hur witz et aI., 1985; Muci-Mendoza et aI., 1980) . Amaurosis fugax usually is produced by emboli that occlude blood vessels to the retina (Adams et aI., 1983; Muci-Mendoza et aI., 1980) , although 30% of patients with episodes of amaurosis have no appar ent source for emboli (Adams et aI., 1983) .
We now propose that vasospasm may contribute to amaurosis, and that this mechanism is related to platelets. Vasospasm has been strongly implicated duced retinal blood flow (in milliliters per minute per 100 g) from 66 ± 7 (mean ± SE) to 5 ± 2. Infusion of sero tonin in atherosclerotic monkeys abolished the retinal re sponse to light. Thus, atherosclerosis greatly potentiates constrictor responses to serotonin in the retinal circula tion and produces a profound but reversible impairment of retinal function. We propose that altered responses to vasoactive substances that are released by platelets may contribute to the pathogenesis of amaurosis fugax. Key Words: Amaurosis fugax-Vasoconstriction-Sero tonin-Atherosclerosis.
in the pathophysiology of myocardial ischemia and angina pectoris (Ganz and Alexander, 1985) . It has been suggested that, when platelets adhere to ath erosclerotic plaques, the platelets aggregate and re lease their vasoactive substances, including seroto nin and thromboxane (Vanhoutte and Huston, 1985) .
In this study, we examined effects of atheroscle rosis on responsiveness of the retinal circulation to vasoactive stimuli. We studied primates that de velop atherosclerotic plaques that closely resemble lesions that occur in humans. Our hypothesis was that atherosclerosis potentiates vasoconstrictor re sponses to serotonin in the retinal circulation, thereby producing transient impairment of retinal function. Based on the findings, we propose that atherosclerosis may potentiate constrictor re sponses of the retinal circulation to some vasoac tive stimuli, and thereby predispose the retinal cir culation to transient ischemia.
MATERIALS AND METHODS
Two groups of adult male cynomolgus monkeys (Macaca fascicularis) were studied. Eight normal mon-keys were fed commercial laboratory chow (Purina Mon key Chow, Ralston Purina Co. ) that contains approxi mately 4% of total calories from fat and is virtually free of cholesterol. Atherosclerosis was induced by feeding eight monkeys a diet with 41% of total calories from fat and 0. 8% cholesterol for approximately 18 months.
Measurement of blood flow
At the time of study, monkeys were sedated with ket amine (12 mglkg i. m. ) and anesthetized with chloralose (75 mg/kg i. v. ). The monkeys were intubated and venti lated with room air that was supplemented with oxygen. Blood gases and pH were measured frequently and main tained at normal levels.
Microspheres with a mean diameter of 15 fLm were in jected into the left atrium to measure blood flow to the eye, using a method that has been described in detail (AIm and Bill, 1973) . Reference arterial blood samples were withdrawn at 1.03 mUmin starting 20 s before injec tion of microspheres and continuing for 2 min after injec tion. We injected 2 x 106 to 4 X 106 spheres labeled with different isotopes to measure blood flow under control conditions and during infusion of phenylephrine and se rotonin. The order of interventions and isotopes used for each intervention was randomized.
We measured blood flow to the retina and choroid dur ing infusion of serotonin (40 fLg/kg/min in the left atrium) and infusion of phenylephrine (25 fLg/kg/min i. v. ). Sero tonin was infused into the left atrium because, following intravenous injection, 30-90% of serotonin is removed in one passage through the lungs (Thomas and Vane, 1967) . During infusion of phenylephrine, mean arterial pressure was maintained at control levels by removing blood. In normal monkeys, mean arterial pressure was 79 ± 3 mm Hg under control conditions, 76 ± 4 mm Hg during infu sion of phenylephrine, and 69 ± 2 mm Hg during seroto nin. In atherosclerotic monkeys, mean arterial pressure was 79 ± 5 mm Hg under control conditions, 78 ± 6 mm Hg during phenylephrine, and 82 ± 6 mm Hg during se rotonin. In three normal and three atherosclerotic mon keys, we measured intraocular pressure. Intraocular pressure was approximately 15 mm Hg under control con ditions in normal and atherosclerotic monkeys, and it did not change during infusion of phenylephrine or serotonin.
The monkeys were sacrificed with KCI i.v. at the end of the experiment, while they were anesthetized. The eyes were removed and placed in 10% buffered formalin for 2 days. A circumferential incision was made through the sclera, choroid, and retina, just posterior to the ciliary body, to separate the eye into anterior and posterior seg ments. Tissue samples were obtained from the posterior two-thirds of the eye. The retina was pealed from the choroid and the choroid was scraped from the sclera. A portion of the parietal cortex also was excised. Samples of retina, choroid, and cerebrum were placed in pre weighed tubes. Wet weight was determined, and then the samples of retina and choroid were frozen with liquid nitrogen and lyophilized, and dry weight was determined. Because vitreous adheres to the retina, blood flow was calculated per dry weight to reduce variability. Tissue samples, together with reference blood samples, were counted in a gamma counter as described previously (Dole et aI. , 1982; Heistad et al. , 1987) . Blood flow was calculated from the equation: Flow (ml/min/100 g tissue) = (counts/g of tissue x 100 x rate of withdrawal of ref- 1989 erence arterial blood samples in ml/min) divided by total counts in reference arterial blood samples.
Electroretinogram
To evaluate retinal function, electroretinograms (ERGs) were performed in four normal and four athero sclerotic monkeys. The pupil was dilated with 1% atro pine solution. A strobe light was used to produce a po tential electrical difference in the outer layers of the ret ina. The ERG is a recording of the potential electrical difference traveling from the outer to the inner cell layers of the retina. The ERGs were obtained with a 604C av erager, which is an evoked response averaging system. Electroretinograms were obtained before and during in fusion of phenylephrine, and before, during, and approx imately 30 min after stopping infusion of serotonin.
Morphological examination
The common carotid, internal carotid, and ophthalmic arteries were examined grossly for the extent of athero sclerosis. Sections of formalin-fixed arteries were exam ined with light microscopy. Area of intima was deter mined in common carotid, internal carotid, and ophthal mic arteries (Armstrong et aI. , 1985) .
Platelet aggregation
We determined in vitro whether the concentration of serotonin in the blood of normal or atherosclerotic mon keys was sufficient to aggregate platelets. A platelet ag gregometer was used to detect an increase in transmitted light as platelets aggregated (Born and Cross, 1963) . Us ing platelet-rich and platelet-poor plasma from three nor mal and three atherosclerotic monkeys (Woods et aI. , 1976) , effects of serotonin (10-5 M) were examined. Re sponses to ADP (10-4 M) also were examined to test the sensitivity of the method.
RESULTS

Plasma lipids
Plasma cholesterol increased approximately five fold within 2 months after starting the atherogenic diet, and changed little thereafter. At the terminal measurement, total cholesterol was 93 ± 9 (mean ± SE) mg/dl in normal monkeys and 592 ± 43 mg/dl in atherosclerotic monkeys. The increase in choles terol is produced primarily by an increase in con centration of low density lipoproteins.
Morphology
In normal monkeys, the common carotid, internal carotid, and ophthalmic arteries were thin-walled, without gross or microscopic evidence of athero sclerotic lesions. In monkeys that were fed athero genic diet, lesions in the common and proximal in ternal carotid arteries ranged from fatty streaks to fibrofatty plaques. Microscopic examination showed diffuse lesions throughout the common and proximal internal carotid arteries (Fig. O . Ophthal mic arteries did not have gross evidence of athero sclerotic lesions, but they often had microscopic evidence of early lesions. Intracranial internal ca rotid arteries and ophthalmic arteries did not have atherosclerotic lesions.
Intimal area was <0.01 mm2 in common carotid arteries in normal monkeys and 1.3 ± 0.4 mm2 in atherosclerotic monkeys. Area of intima in extra cranial internal carotid arteries was <0.01 mm2 in normal monkeys and 0.7 ± 0.2 mm2 in atheroscle rotic monkeys.
Blood flow
Control blood flow to the cerebrum was 46 ± 6 mllminilOO g in normal monkeys and 42 ± 5 mil minll00 g in atherosclerotic monkeys. In both nor mal and atherosclerotic monkeys, phenylephrine and serotonin had little effect on blood flow to ce rebrum. During infusion of phenylephrine, cerebral blood flow was 44 ± 5 and 40 ± 6 ml/minilOO g in normal and atherosclerotic monkeys, respectively. During infusion of serotonin, cerebral blood flow was 55 ± 10 and 38 ± 5 mllmin/IOO g in normal and atherosclerotic monkeys, respectively.
Blood flow to choroid under control conditions was 2,174 ± 350 mllminilOO g dry weight in normal monkeys and 2,188 ± 343 mllmin/lOO g dry weight in atherosclerotic monkeys. Phenylephrine had lit tle effect on blood flow to choroid in normal or atherosclerotic monkeys. Serotonin did not reduce blood flow to choroid in normal monkeys (2,116 ± 393). Serotonin, however, produced a sevenfold re duction in blood flow to choroid (to 305 ± 73) in atherosclerotic monkeys, which returned to normal (1, 994 ± 391) within 30 min after stopping infusion of serotonin.
Phenylephrine had little effect on blood flow to retina in normal and atherosclerotic monkeys. Se rotonin had little effect on blood flow to retina of normal monkeys (Fig. 2) . Serotonin, however, pro duced a decrease in blood flow to the retina of ath erosclerotic monkeys to one-seventh (Fig. 2) . Blood flow to retina returned to normal within 30 min after stopping infusion of serotonin (Fig. 2) . 1. K. WILLIAMS ET AL.
Platelet aggregation
Serotonin (10-5 M), which is about 10-fold greater than the concentration that we estimate oc curred in vivo, did not produce aggregation of plate lets from normal or atherosclerotic monkeys. Thus, it is very unlikely that changes in blood flow that were induced by serotonin were related to forma tion of platelet aggregates. ADP (10-4 M) produced rapid aggregation of platelets, which indicates that the method was sensitive.
Electroretinogram
In normal monkeys, the ERG was 41 ± 7 f1 V during control conditions and 37 ± 5 f1 V during infusion of serotonin. Thus, infusion of serotonin did not alter the ERG. In atherosclerotic monkeys, serotonin produced a profound decrease in the ret inal response to the light stimulus ( Fig. 2 and 3) . The retinal response returned to normal within 30 min after stopping infusion of serotonin (Fig. 2) .
DISCUSSION
The major new finding in this study is that sero tonin produced a profound but reversible decrease in blood flow to the choroid and retina in athero sclerotic monkeys, but not in normal monkeys. Se rotonin also produced a profound but reversible im pairment of retinal function, as demonstrated by electroretinograms, in atherosclerotic monkeys.
Methods and design
Microspheres have been used previously to mea sure blood flow to choroid and retina (AIm and Bill, 1973) . The studies indicate that assumptions of the microsphere method, in relation to minimal arterio- venous shunting and rheological characteristics of spheres, are valid in relation to measurement of oc ular blood flow (AIm and Bill, 1973) . Values for blood flow to retina and choroid obtained in this study were similar to values obtained in other stud ies (AIm and Bill, 1973) . We have estimated the concentration of serotonin that was achieved during infusion of serotonin in these experiments and compared this value with blood levels that have been observed in vivo. We assumed that 90% of serotonin is cleared in one passage through the pulmonary circulation, that the circulation time in monkeys is 14 s, and that the space of distribution of serotonin is limited to plasma. We thereby estimated that infusion of 40 f1g/kg/min of serotonin into the left atrium produces a plasma concentration of 215 nglml. For compari son, partial occlusion of a coronary artery with a thrombus increases the level of serotonin in blood distal to the occlusion from 9 to 213 ng/ml (Ashton et aI., 1986; Benedict et aI., 1986) . Thus, the con centration of serotonin in blood that was achieved in this study is similar to the concentration that may occur in pathophysiological states.
Blood flow to the eye
Atherosclerosis potentiated constrictor re sponses in the ocular circulation to serotonin, which resulted in a profound decrease in blood flow to the choroid and retina. Blood flow returned to normal after infusion of serotonin was stopped, which indicates that the effect of serotonin is tran sient.
Primates may have connections, via the orbit, be tween branches of the external and internal carotid arteries. Infusion of serotonin into the left atrium may affect blood flow through both the external and internal carotid arteries. Thus, it is not clear whether reduction in blood flow to the eye during infusion of serotonin in atherosclerotic monkeys is the result of constriction of the internal carotid ar tery and/or possibly the external carotid artery, or their branches.
Electroretinograms in atherosclerotic monkeys indicated that the retinal response to a flash of light was virtually abolished during infusion of serotonin. The "flat" ERG, which occurred in all four ath erosclerotic monkeys, suggests profound functional impairment of the retina. Thus, the reduction in blood flow to the retina during infusion of serotonin in atherosclerotic monkeys was sufficient to pro duce retinal ischemia. These findings indicate that serotonin produced both a profound decrease in blood flow to the eye and marked impairment of retinal function in atherosclerotic monkeys.
Blood flow to cerebrum
The choroid and retina receive blood flow through the ophthalmic artery, which is the first intracranial branch of the internal carotid artery. Infusion of serotonin reduced blood flow to the eye, probably in part because the eye has an "end organ" type of blood supply. In contrast, serotonin did not affect blood flow to cerebrum, even in ath erosclerotic monkeys. We have shown previously that serotonin constricts large cerebral arteries and reduces microvascular resistance in cerebral ves sels (Heistad et ai., 1987) , but serotonin does not reduce cerebral blood flow. Maintenance of cere bral blood flow, despite constriction of large arter ies, is related to dilatation of arterioles (Heistad et ai., 1987) and, most likely, to collateral circulation through the circle of Willis.
Mechanism of altered vascular responses
Several stimuli, including acetylcholine and sero tonin, release a vasodilator substance from endo thelium which is called endothelium-derived relax ant factor (EDRF) (Furchgott, 1983) . In coronary arteries, serotonin produces both vasoconstriction, by a direct effect on vascular muscle, and vasodi latation by release of EDRF (Cohen et ai., 1983a) , so that the net response in different vascular segments depends on which effect is predominant.
In cerebral arteries, the role of endothelium in modulation of responses to serotonin is not clear. Serotonin produces endothelium-dependent con striction in pial arteries of mice (Rosenblum and Nelson, 1988) , but releases EDRF from basilar ar teries in dogs and rabbits (Nakagomi et ai., 1988) . In light of regional and species differences with re spect to endothelial modulation of responses to se rotonin, release of EDRF by serotonin in cerebral or cephalic arteries should be considered an hy pothesis, not a fact.
When endothelium is removed from a blood ves sel, the normal vasodilator response to platelets is reversed to vasoconstriction (Cohen et ai., 1983b) . We speculate that a similar mechanism may con tribute to abnormal vascular responses to platelets in atherosclerotic nonhuman primates. Although endothelium is present in atherosclerotic arteries, the endothelium is dysfunctional, resulting in im paired endothelium-dependent relaxation (Freiman et ai., 1986; Habib et ai., 1986; Verbeuren et ai., 1986) . Thus, it seems likely that a functional abnor mality of endothelium may lead to vasoconstriction, instead of relaxation, when platelets adhere and ag gregate in atherosclerotic arteries. It is likely that several vasoactive products, including serotonin, that are released by platelets may mediate the re-sponse to adhesion and aggregation of platelets (Houston et aI., 1986) .
Implications for amaurosis fugax and transient cerebral ischemia
An important role of platelet aggregation and thrombi has been well documented in the patho physiology of cerebral ischemia (Muci-Mendoza et ai., 1980; Rosenblum, 1986; Tomsak, 1985) . Phar macological treatment of amaurosis and transient cerebral ischemia is aimed at preventing the forma tion of platelet aggregates and thrombi (Kistler et aI., 1984) .
Numerous studies have implicated vasospasm in the pathophysiology of ischemic events (Cohen et aI., 1983a,b; Ganz and Alexander, 1985; Rosenblum, 1986; Vanhoutte and Huston, 1985) . In this study, we provide the first evidence that serotonin, which is released when platelets aggregate, can produce ischemia of the retina in the presence of atheroscle rotic vascular disease. Our data lead us to propose that vasospasm, perhaps mediated in part by sero tonin that is released by platelets, may play an im portant role in the pathogenesis of amaurosis fugax.
